Literature DB >> 20631990

Macrolide combination antibiotic therapy should be prudently considered in complicated CAP cases and in regions with low macrolide susceptibility.

Hsin-I Shih1, Hsiang-Chin Hsu2, Chih-Hsien Chi2, Wen-Chien Ko3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20631990     DOI： 10.1007/s00134-010-1946-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan.

Authors:  P-R Hsueh
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

2.  Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.

Authors:  I Martin-Loeches; T Lisboa; A Rodriguez; C Putensen; D Annane; J Garnacho-Montero; M I Restrepo; J Rello
Journal:  Intensive Care Med       Date:  2009-12-02       Impact factor: 17.440

3.  Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.

Authors:  Alejandro Rodríguez; Angel Mendia; Josep-María Sirvent; Fernando Barcenilla; María Victoria de la Torre-Prados; Jordi Solé-Violán; Jordi Rello
Journal:  Crit Care Med       Date:  2007-06       Impact factor: 7.598

4.  Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).

Authors:  Jae-Hoon Song; Hyun-Ha Chang; Ji Yoeun Suh; Kwan Soo Ko; Sook-In Jung; Won Sup Oh; Kyong Ran Peck; Nam Yong Lee; Yonghong Yang; Anan Chongthaleong; Nalinee Aswapokee; Cheng-Hsun Chiu; M K Lalitha; Jennifer Perera; Ti Teow Yee; Gamini Kumararasinghe; Farida Jamal; Adeeba Kamarulazaman; Navaratnam Parasakthi; Pham Hung Van; Thomas So; Tak Keung Ng
Journal:  J Antimicrob Chemother       Date:  2004-02-12       Impact factor: 5.790

5.  Antimicrobial resistance in Streptococcus pneumoniae, Taiwan.

Authors:  Po-Ren Hsueh; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.